Swiss All Share Index
15.070,92
PKT
-30,75
PKT
-0,20
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.05.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 07.05.24 | UBS Kaufen | DZ BANK | |
| 07.05.24 | UBS Hold | Jefferies & Company Inc. | |
| 07.05.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.05.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 07.05.24 | UBS Outperform | RBC Capital Markets | |
| 06.05.24 | Roche Neutral | UBS AG | |
| 06.05.24 | Novartis Buy | UBS AG | |
| 03.05.24 | Swiss Re Equal Weight | Barclays Capital | |
| 02.05.24 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 02.05.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 02.05.24 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.24 | ams-OSRAM Buy | Deutsche Bank AG | |
| 30.04.24 | Nestlé Buy | Deutsche Bank AG | |
| 29.04.24 | Nestlé Kaufen | DZ BANK | |
| 29.04.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 26.04.24 | Nestlé Buy | UBS AG | |
| 26.04.24 | Nestlé Add | Baader Bank | |
| 26.04.24 | Holcim Hold | Deutsche Bank AG | |
| 26.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 25.04.24 | Nestlé Add | Baader Bank | |
| 25.04.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 25.04.24 | Nestlé Buy | Deutsche Bank AG | |
| 25.04.24 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 25.04.24 | Roche Neutral | UBS AG | |
| 25.04.24 | Roche Equal Weight | Barclays Capital | |
| 25.04.24 | Nestlé Sector Perform | RBC Capital Markets | |
| 24.04.24 | Roche Kaufen | DZ BANK | |
| 24.04.24 | Novartis Buy | UBS AG | |
| 24.04.24 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 24.04.24 | Roche Equal Weight | Barclays Capital | |
| 24.04.24 | Novartis Buy | Deutsche Bank AG | |
| 24.04.24 | Roche Neutral | UBS AG | |
| 24.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | Roche Hold | Jefferies & Company Inc. | |
| 24.04.24 | Roche Outperform | Bernstein Research | |
| 24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | UBS Outperform | RBC Capital Markets | |
| 23.04.24 | Novartis Underweight | Barclays Capital |